Financials
- Market Capitalization 534.24 M
- Employee 246
- Founded 2013
- CEO N/A
- Website www.arvinas.com
- Headquarter Delaware, United States
- FIGI BBG00LW7YK82
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2839 | IMMX Immix Biopharma, Inc. - Common Stock | 10.53 USD | -1.40% | -4.27% | +23.88% | +273.40% | 572.95 M USD | ||
| 2850 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 9.02 USD | -0.33% | -1.96% | +10.95% | +1.58% | 562.17 M USD | ||
| 2911 | NVCT Nuvectis Pharma, Inc. - Common Stock | 19.59 USD | +7.11% | +4.48% | +74.29% | +139.19% | 519.64 M USD | ||
| 2914 | ZURA Zura Bio Limited - Class A Ordinary shares | 5.39 USD | +6.52% | -1.82% | +46.87% | +308.33% | 512.04 M USD |
Frequently asked questions about Arvinas, Inc. - Common Stock
What is the Arvinas, Inc. - Common Stock stock price today?
The current price of Arvinas, Inc. - Common Stock (ARVN) is 8.28. Over the past 24 hours, the stock has changed by +0.12%. Follow the ARVN chart for real-time price dynamics.
What is the stock ticker of Arvinas, Inc. - Common Stock?
Arvinas, Inc. - Common Stock trades under the ticker ARVN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Arvinas, Inc. - Common Stock stock going up?
ARVN has changed by -3.27% over the last week, +10.84% over the last month, and -10.97% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Arvinas, Inc. - Common Stock net income for the last quarter?
Arvinas, Inc. - Common Stock reported net income of -57.6 M for the last quarter. The previous quarter showed -67.4 M, which means net income changed by +14.54%.
How many employees does Arvinas, Inc. - Common Stock have?
As of the latest available data, Arvinas, Inc. - Common Stock has 246 employees. Workforce size can provide additional context about the company's scale and operations.
What is Arvinas, Inc. - Common Stock EBITDA?
Arvinas, Inc. - Common Stock EBITDA is -65.5 M, and its EBITDA margin is -419.87%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Arvinas, Inc. - Common Stock stock?
You can buy Arvinas, Inc. - Common Stock (ARVN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Arvinas, Inc. - Common Stock stock?
Investing in Arvinas, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ARVN chart and related analysis on metatrader.com as part of your research.